01 ↗
M&A M&A
Identifying and evaluating M&A opportunities with strategic value to support corporate strategic expansion, business integration, product pipeline enhancement, and market entry goals.
02 M&A ADVISORY
M&A and Divestiture
Advisory for Healthcare Companies
From M&A strategy, target and buyer screening, to transaction structuring, business negotiations, and deal execution, T-Capital provides professional transaction advisory services for healthcare companies and industry investors.
HEALTHCARE M&A ADVISORY STRATEGY · TRANSACTION · VALUE
01 WHY M&A
M&A is Not Just About
Buying and Selling.
In a healthcare M&A transaction, the real issue to be addressed is usually not "are there any deal opportunities," but rather why the company is transacting, what value the transaction can create, and how to make the transaction happen.
For the buyer, an acquisition may be a way to enter a new market, supplement products and technologies, gain industrial capabilities, or accelerate business growth. For the seller, a sale may involve shareholder exit, strategic adjustment, asset value realization, or finding a new platform for industrial development.
T-Capital starts from strategic objectives, combining industrial and transactional logic to help clients identify transaction opportunities, screen counterparties, and drive deal execution.
02 TRANSACTION TYPES
Different Transaction Objectives,
Different Transaction Paths.
T-Capital provides advisory services from strategic assessment to transaction execution, catering to the different transaction needs of healthcare companies and industrial capital.
02 ↗
SALE & DIVESTITURE Sale & Divestiture
Providing sell-side strategies, potential buyer screening, transaction arrangement, and negotiation support for shareholders, companies, and investors to help realize the value of assets or equity.
03 ↗
STRATEGIC INVESTMENT Strategic Investment
Connecting healthcare industry capital with high-quality companies or projects to establish investment relationships focused on business synergy, product capabilities, channels, and long-term strategy.
04 ↗
EQUITY TRANSACTIONS Equity Transactions
Designing executable solutions for equity transfers, shareholder exits, asset integration, and other complex equity transaction needs, tailored to the transaction objectives.
03 BUY-SIDE ADVISORY
Finding Targets with
Real Value for Buyers.
The core of M&A is not to find the largest number of target companies, but to find those that can solve strategic problems and create long-term value.
DEFINE
Define M&A Strategy
Starting from the corporate strategy to clarify what problems the acquisition is intended to solve and what core capabilities the target company needs to possess.
SOURCE
Source Targets
Screening potential targets based on industry, product, technology, market, geography, and strategic synergy, and initiating preliminary contact.
ASSESS
Assess Transaction Value
Analyzing the target company from business, commercial, financial, and strategic synergy perspectives, and supporting discussions on transaction value and structure.
EXECUTE
Execute Transaction
Coordinating key aspects such as communication between buyer and seller, due diligence, transaction terms, agreement negotiations, and closing.
04 STRATEGIC FIT
A Good M&A
is a Strategic Fit.
The value of a healthcare M&A often comes from the synergy between the two parties, not just the target company\'s current financial performance.
Product Synergy Supplementing product pipelines, therapeutic areas, or product portfolios.
Technology Synergy Acquiring core technologies, R&D platforms, or specialized expertise.
Market Synergy Entering new markets, customer segments, or commercial channels.
Industrial Synergy Strengthening supply chain, manufacturing, R&D, and industrial ecosystem capabilities.
Global Synergy Gaining access to international markets, cross-border products, and global industrial resources.
05 SELL-SIDE ADVISORY
Realizing Asset Value
for Sellers.
Selling a business is not just about finding a buyer. How you position the asset\'s value, select a counterparty, structure the deal, and protect shareholder interests during negotiations also determine the final outcome.
Position for Sale
Articulating the core value of the company and its assets to define the transaction logic and identify suitable buyer types.
Identify Buyers
Screening potential buyers based on industrial synergy, financial strength, strategic direction, and transaction capabilities.
Negotiate Transaction
Assisting in managing buyer communications, offers, transaction structuring, and discussions on key commercial terms.
Close the Deal
Assisting in advancing due diligence, legal documentation, and transaction closing to move the deal from intent to completion.
06 HEALTHCARE SECTORS
Deep Expertise in Healthcare,
Understanding Industrial Value.
Healthcare transactions involve multiple factors, including R&D, technology, products, registration, commercialization, and industrial synergy. Industry understanding is an important basis for judging transaction value and potential counterparties.
BIOPHARMA
Biopharma
M&A opportunities related to innovative drug companies, R&D platforms, drug assets, and biotechnology.
MEDICAL DEVICES
Medical Devices
Areas such as innovative medical devices, high-value consumables, equipment, and implantable/interventional products.
DIAGNOSTICS
Diagnostics
IVD, molecular diagnostics, medical laboratories, and related diagnostic technologies and platforms.
HEALTHCARE SERVICES
Healthcare Services
Medical service institutions, specialty medical services, healthcare service platforms, and related assets.
AI & HEALTHCARE
AI & Healthcare
Artificial intelligence, digital health, health IT, and technology-driven healthcare companies.
HEALTH & WELLNESS
Health & Wellness
Companies and assets in consumer health, wellness management, and other areas of the broader health and wellness industry.
07 TRANSACTION EXECUTION
From First Contact
to Final Closing.
Complex transactions require continuous management of multiple participants and key milestones. T-Capital participates in the core communication and coordination throughout the transaction process to drive the deal forward.
01
Strategy & Transaction Goals
Clarify the rationale for the transaction, strategic objectives, and key conditions.
02
Target / Buyer Screening
Create a list of potential counterparties and initiate preliminary contact.
03
LOI & Business Negotiations
Drive discussions on offers, transaction structure, and key commercial terms.
04
Due Diligence
Coordinate relevant due diligence work with the company and professional advisors.
05
Agreements & Closing
Drive the finalization of transaction documents, fulfillment of conditions, and closing.
08 TCAPITAL TRANSACTIONS
Transaction Experience
from Real Projects.
T-Capital has a long-term focus on capital transactions in the healthcare industry, with experience covering various scenarios, including financing, M&A, divestitures, licensing, and cross-border transactions.
Specific case studies will be disclosed gradually in accordance with project confidentiality arrangements.
View T-Capital Transactions → 09 FAQ
Healthcare M&A
Frequently Asked Questions.
If you are considering an M&A, sale, or strategic investment, you can discuss your specific transaction needs directly with the T-Capital team.
Discuss Your Transaction Needs →What healthcare M&A services does T-Capital provide?
T-Capital provides advisory services for M&A, divestitures, equity transactions, and strategic investments in the healthcare sector. This includes M&A strategy analysis, target screening, potential counterparty matching, transaction value analysis, transaction structuring discussions, business negotiations, due diligence coordination, and transaction execution support.
Does T-Capital serve both buyers and sellers?
Yes. T-Capital can provide buy-side or sell-side advisory services depending on the project. Buy-side advisory typically focuses on M&A strategy, target sourcing, transaction value, and integration logic. Sell-side advisory focuses on asset positioning, potential buyer screening, transaction arrangement, offers, and negotiations.
Under what circumstances should a company consider an M&A?
M&A may be appropriate when a company wants to quickly enter a new market, supplement its product or technology capabilities, gain access to industry channels, expand its business scale, or build new strategic capabilities. The suitability of an M&A needs to be judged comprehensively based on the company's strategic goals, the quality of the target, transaction costs, and integration capabilities.
How do you identify potential buyers when selling a business?
Potential buyers are not limited to traditional financial investors but may also include industrial groups, listed companies, multinational corporations, and other companies with strategic synergy value. When screening buyers, it is necessary to consider their industry focus, financial capacity, synergy value, transaction appetite, and execution capabilities.
Does T-Capital participate in due diligence in M&A transactions?
T-Capital can assist companies in organizing and advancing commercial and transaction-level due diligence and can coordinate communication between the company and legal, financial, technical, and other professional advisors. The specific scope of work is determined by the project's transaction structure and the client's needs.
Why is a professional industry advisor needed for a healthcare M&A?
The value of a healthcare company can involve multiple dimensions, such as R&D pipelines, technology platforms, product registration, commercialization capabilities, channels, clinical resources, and industrial synergy. Industry understanding helps to more accurately identify the transaction logic, potential buyers, and the value of the target.
M&A ADVISORY
Looking for M&A Opportunities,
Looking for M&A Opportunities,
or Considering Selling a Business?
Tell us your transaction goals, industry focus, and current stage, and let\'s discuss possible transaction paths together with T-Capital.
Contact Us →